Yusuke Kondo

Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure

H. Kusuhara, T. Tsunoda, K. Fujita, 2021, Cancer Chemotherapy and Pharmacology.

Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs

H. Kusuhara, Y. Sugiyama, E. Kimoto, 2020, Clinical pharmacology and therapeutics.

Alteration in the Plasma Concentrations of Endogenous Organic Anion–Transporting Polypeptide 1B Biomarkers in Patients with Non–Small Cell Lung Cancer Treated with Paclitaxel

K. Maeda, H. Kusuhara, S. Kusumoto, 2020, Drug Metabolism and Disposition.

Diabetes Evaluation Sheet

H. Katsuyama, H. Yanai, Hiroki Adachi, 2018 .

Alteration in the Plasma Concentrations of Endogenous Organic Anion–Transporting Polypeptide 1B Biomarkers in Patients with Non–Small Cell Lung Cancer Treated with Paclitaxel

K. Maeda, H. Kusuhara, S. Kusumoto, 2020, Drug Metabolism and Disposition.

Alteration in the plasma concentrations of endogenous OATP1B-biomarkers in non-small cell lung cancer patients treated with paclitaxel

K. Maeda, H. Kusuhara, S. Kusumoto, 2020 .